Literature DB >> 18413201

Diabetic myocardial disease: pathophysiology, early diagnosis and therapeutic options.

Dimitrios Z Mytas1, Pavlos N Stougiannos, Michael N Zairis, Stefanos G Foussas, Vlassios N Pyrgakis, Ioannis A Kyriazis.   

Abstract

Diabetes mellitus is a powerful risk factor for cardiovascular disease associated with high morbidity and mortality rates. Diabetic patients also have an increased incidence of heart failure which has been traditionally attributed to the concurrent presence of ischemic or hypertensive heart disease. Yet, nowadays, according to recent scientific evidence, diabetic myocardial disease (DMD) is more and more being considered as a distinct nosologic entity, independent of the co-existence of coronary artery disease, arterial hypertension or other risk factors, with the potential to lead to a self-existent progressive development of heart failure. In this article, we review the possible pathophysiologic mechanisms involved in the development of DMD as well as the structural and functional changes in the diabetic heart. We emphasize the importance of early detection of the syndrome, especially by novel echocardiographic techniques. Finally, we refer to the various therapeutic options for the optimal management of DMD according to the recent literature.

Entities:  

Mesh:

Year:  2008        PMID: 18413201     DOI: 10.1016/j.jdiacomp.2007.12.005

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  10 in total

Review 1.  Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.

Authors:  Guanghong Jia; Adam Whaley-Connell; James R Sowers
Journal:  Diabetologia       Date:  2017-08-03       Impact factor: 10.122

2.  A review of cardiovascular risks associated with medications used to treat type-2 diabetes mellitus.

Authors:  Erin L St Onge; Carol Anne Motycka; Shannon A Miller
Journal:  P T       Date:  2009-07

Review 3.  Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.

Authors:  Guanghong Jia; Michael A Hill; James R Sowers
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

4.  Update on diabetic cardiomyopathy: inches forward, miles to go.

Authors:  Maggie N Tillquist; Thomas M Maddox
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

Review 5.  Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence.

Authors:  Sunil Rupee; Khemraj Rupee; Ram B Singh; Carlin Hanoman; Abla Mohammed Ahmed Ismail; Manal Smail; Jaipaul Singh
Journal:  Heart Fail Rev       Date:  2022-09-15       Impact factor: 4.654

Review 6.  Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.

Authors:  Guanghong Jia; Vincent G DeMarco; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2015-12-18       Impact factor: 43.330

Review 7.  Subcellular microRNAs in diabetic cardiomyopathy.

Authors:  Huaping Li; Jiahui Fan; Chen Chen; Dao Wen Wang
Journal:  Ann Transl Med       Date:  2020-12

Review 8.  The Role of Epicardial Adipose Tissue in the Development of Atrial Fibrillation, Coronary Artery Disease and Chronic Heart Failure in the Context of Obesity and Type 2 Diabetes Mellitus: A Narrative Review.

Authors:  Anirudh Krishnan; Harman Sharma; Daniel Yuan; Alexandra F Trollope; Lisa Chilton
Journal:  J Cardiovasc Dev Dis       Date:  2022-07-05

9.  Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.

Authors:  Oghenerukevwe Odiete; Ewa A Konik; Douglas B Sawyer; Michael F Hill
Journal:  Cardiovasc Diabetol       Date:  2013-03-27       Impact factor: 9.951

10.  Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study.

Authors:  Leif Brunvand; Drude Fugelseth; Knut Håkon Stensaeth; Knut Dahl-Jørgensen; Hanna Dis Margeirsdottir
Journal:  BMC Cardiovasc Disord       Date:  2016-05-25       Impact factor: 2.298

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.